Trial Profile
A RANDOMIZED TRIAL COMPARING EPTIFIBATIDE AND PLACEBO IN PATIENTS WITH DIFFUSE CORONARY DISEASE UNDERGOING DRUG-ELUTING STENTING.
Status:
Discontinued
Phase of Trial:
Phase IV
Latest Information Update: 10 Nov 2021
Price :
$35
*
At a glance
- Drugs Eptifibatide (Primary) ; Heparin
- Indications Coronary artery disease; Myocardial ischaemia; Stent thrombosis
- Focus Therapeutic Use
- Acronyms INSTANT
- 30 Jun 2012 European Clinical Trials Database record Actual Initiation Date is 23 Jan 2008.
- 18 Oct 2011 Status changed from completed to discontinued as reported by ClinicalTrials.gov.
- 18 Oct 2011 Status changed from completed to discontinued as reported by ClinicalTrials.gov.